Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LUNG-07: Advancing Precision-Based Lung Cancer Screening: Implementation, AI-Guided Risk Stratification, and Biomarker Integration (CREST AI)

NCT07408531 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.

NCT NCT07408531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07408531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LUNG-07: Advancing Precision-Based Lung Cancer Screening: Implementation, AI-Guided Risk Stratification, and Biomarker Integration (CREST AI)
Lead sponsor
University of Illinois at Chicago
Phase
Not applicable
Overall status
Recruiting
Start date
March 12, 2026
Completion date
March 31, 2038
Enrollment
2,500 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer screening